GlassScriptPhysician profile
David Anthony Cortese
NPI 1710098660
$12,379.64
in general payments reported to CMS, 2019-2025
8 companies · $72.33 in 2025
The $72.33 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,074 · 2020: $1,176 · 2021: $2,408 · 2022: $3,281 · 2023: $1,704 · 2024: $2,663 · 2025: $72.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,617 · Food and Beverage: $1,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,617.20 |
| Food and Beverage | $1,822.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Summit Surgical Corp. | $5,110.47 | 2021-2023 | |
| Arthrex, INC. | $2,453.58 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $1,330.59 | 2019-2025 | Comprehensive, Juggerknotless Soft Anchor, Mymobility Platform |
| Smith+Nephew, INC. | $1,246.85 | 2019-2025 | Renasys Go V2 Home, Pico |
| Stryker Corporation | $1,107.15 | 2024 | Mako, Inspace |
| Invictus Surgical Incorporated | $930.76 | 2024 | |
| Miach Orthopaedics, INC. | $185.08 | 2024 | |
| Kci USA, INC. | $15.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cortese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.